Keystone Symposia Scientific Advisory Board
The Scientific Advisory Board (SAB) is comprised of eminent biomedical scientists whose expertise derives from academia, industry, and the government. The SAB is tasked with guiding the development of the conference portfolio, prioritizing content and topics, and providing a substantive peer review process to ensure Keystone Symposia's reputation as the preeminent convener of scientific conferences in the biomedical and life sciences.
To learn more about the functions of the SAB, please click here.
Board of Directors are denoted with a # following their name.|
E. Dale Abel, M.D., Ph.D.#
Director F.O.E. Diabetes Research Center Professor of Medicine and Biochemistry University of Iowa, Carver College of Medicine Clement Adebamowo, B.M., Ch.B., Hons, Sc.D. Professor Epidemiology and Public Health Associate Director Population Science, Greenebaum Comprehensive Cancer Center Member, Institute of Human Virology University of Maryland School of Medicine Karen Adelman, Ph.D. Professor Biological Chemistry and Molecular Pharmacology Harvard Medical School Luciano Adorini, M.D. Chief Scientific Officer Preclinical Research Intercept Pharmaceuticals, Inc. Muhammad Al-Hajj, Ph.D. Senior Vice President Translational Medicine Translational Sciences Autolus Therapeutics Zoltan P. Arany, M.D., Ph.D. Professor Medicine University of Pennsylvania Eric H. Baehrecke, Ph.D. Professor Molecular, Cell and Cancer Biology University of Massachusetts Medical School Yasmine Belkaid, Ph.D. Director NIAID Microbiome Program Chief Mucosal Immunology Section Laboratory of Parasitic Disease NIAID, National Institutes of Health Ralph A. Bradshaw, Ph.D.# Professor Emeritus Department of Physiology and Biophysics University of California, Irvine Cherié L. Butts, Ph.D.# Medical Director Digital & Quantitative Medicine Biogen Inc Robert Califf, M.D., MACC# Head of Medical Strategy and Policy for Verily and Google Health Verily Life Sciences, Google Health Ian M. Colrain, Ph.D.# President SRI International SRI Biosciences Roger D. Cone, Ph.D. Director Life Sciences Institute University of Michigan Feng Cong, Ph.D. Director Chemical Biology & Therapeutics Novartis Institutes for BioMedical Research John E. Connolly, Ph.D. Chief Scientific Officer, Parker Institute for Cancer Immunotherapy Senior Principal Investigator and Director for Translational Immunology, Institute of Molecular and Cell Biology Rodrigo Corrêa-Oliveira, Ph.D. Vice President Research and Biological Collections FIOCRUZ Ana Maria Cuervo, M.D., Ph.D. Professor, Department of Developmental and Molecular Biology Co-Director, Institute for Aging Studies Albert Einstein College of Medicine Robertus de Bruin, Ph.D. Professor, Molecular Cancer Biology MRC Laboratory for Molecular Cell Biology University College London Robert J. Deans, Ph.D. Chief Scientific Officer Synthego Corporation Russell A. DeBose-Boyd, Ph.D. Professor Molecular Genetics University of Texas Southwestern Medical Center Edward A. Dennis, Ph.D.# Chancellor Distinguished Professor Chemistry, Biochemistry and Pharmacology School of Medicine University of California, San Diego Suzanne Devkota, Ph.D. Assistant Professor Karsh Division of Gastroenterology Cedars-Sinai Medical Center Vishva M. Dixit, M.D.# Vice President, Early Discovery Research and Physiological Chemistry Genentech, Inc. Aris N. Economides, Ph.D. Vice President Research Regeneron Pharmaceuticals, Inc. Kelly A. Frazer, Ph.D. Professor, Pediatrics Director, Institute for Genomic Medicine University of California San Diego School of Medicine Mattias Fyrenius# Publishing Director Bonnier Carlsen Stephan Gasser, Ph.D. Senior Principal Scientist CIT-4 Roche Innovation Center Zurich Paloma Giangrande, Ph.D. Director, Rare Disease, Moderna Associate Professor, Internal Medicine University of Iowa Geoffrey S. Ginsburg, M.D., Ph.D.# Director The Duke Center for Applied Genomics & Precision Medicine Duke University Margaret A. Goodell, Ph.D.# Professor and Chair Department of Molecular and Cellular Biology Director of Stem Cells & Regenerative Medicine Center Vivian L. Smith Chair of Regenerative Medicine Baylor College of Medicine Curtis C. Harris, M.D.# Chief, Laboratory of Human Carcinogenesis NCI / National Institutes of Health Tim Harris, Ph.D. Venture Partner SV Health Investors Lora K. Heisler, Ph.D. Chair in Human Nutrition Obesity and Food Choice Rowett Institute, University of Aberdeen De' Broski R. Herbert, Ph.D.# Associate Professor of Immunology Department of Pathobiology University of Pennyslvania Linda Slanec Higgins, Ph.D. Senior Vice President , Biology Gilead Sciences, Inc. Sean Hill, Ph.D. Director, Krembil Centre for Neuroinformatics Centre for Addiction and Mental Health Professor, Department of Psychiatry, University of Toronto Professor, Blue Brain Project, École Polytechnique Fédérale de Lausanne (EPFL) Robert J. Hofmeister, Ph.D. Chief Scientific Officer TCR2 Therapeutics Pamela M. Holland, Ph.D. Vice President Cancer Biology Surface Oncology Michael J. Holtzman, M.D. Selman and Herman Seldin Professor, Medicine Director, Pulmonary and Critical Care Medicine Professor, Cell Biology and Physiology Washington University in St. Louis Tony Hunter, Ph.D.# Professor and Principal Investigator Molecular Cellular Biology Laboratories The Salk Institute for Biological Sciences Aron B. Jaffe, Ph.D. Entrepreneur-in-Residence Third Rock Ventures Thale C. Jarvis, Ph.D.# Chief Scientific Officer Keystone Symposia Sally John, Ph.D. Vice President, Translational Biology Research and Early Development Biogen Deborah L. Johnson, Ph.D.# President and Chief Executive Officer Keystone Symposia on Molecular and Cellular Biology Takashi Kadowaki, M.D., Ph.D. Professor and Chairman Graduate School of Medicine, Diabetes and Metabolic Diseases University of Tokyo Véronique Kiermer, Ph.D.# Executive Editor and Publisher Publishing and Editorial Public Library of Science (PLOS) Karla A. Kirkegaard, Ph.D. Violetta Horton Professor Genetics & Microbiology & Immunology Stanford University School of Medicine Melanie A. Kleinschek, D.V.M., Ph.D. Chief Scientific Officer TRex Bio Mark Kowala, B.Sc., Ph.D. Chief Scientific Officer Cardiometabolic Eli Lilly Research Lab Martin Kussmann, Ph.D. Senior Scientist Vydiant Jeffery L. Kutok, M.D., Ph.D. Chief Scientific Officer Epizyme, Inc. Tony K.T. Lam, Ph.D. Professor and J.K. McIvor Endowed Chair in Diabetes Research Canada Research Chair in Obesity Associate Director, Banting and Best Diabetes Centre Advanced Diagnostics and Metabolism Toronto General Research Institute Dangsheng Li, Ph.D. Deputy Editor-in-Chief Cell Research Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences |
Jean K. Lim, Ph.D.
Associate Professor Microbiology Icahn School of Medicine at Mount Sinai Sarah Lively, Ph.D. Vice President, Innovation and New Technologies Head, San Francisco Site ChemPartner Corporation Juan Carlos Lopez, Ph.D.# Founder Haystack Science Patrick Mayes, Ph.D. Executive Director Immuno-Oncology Antibodies Incyte Research Institute M. Juliana McElrath, M.D., Ph.D. Senior Vice President, Director and Member Vaccine and Infectious Disease Division Fred Hutchinson Cancer Research Center Valerie Mizrahi, Ph.D. Director Institute of Infectious Disease and Molecular Medicine (IDM) University of Cape Town Craig Monell, Ph.D. Vice President Business Operations/R&D BioLegend, Inc. Walter H. Moos, Ph.D.# Managing Director, Pandect Bioventures CEO, ShangPharma Innovation Professor (adj.), University of California, San Francisco President (ret.), SRI Biosciences Richard A. Morgan, Ph.D. Senior Vice President Immunogenetics Editas Medicine Lily Y. Moy, Ph.D. Director, Pharmacology Quantitative Biosciences Merck & Co. Dominik Mumberg, Ph.D. Vice President Oncology II Bayer AG Leon O. Murphy, Ph.D. Chief Scientific Officer Casma Therapeutics Lee A. Niswander, Ph.D. Professor and Chair Molecular, Cellular and Developmental Biology University of Colorado Boulder Anne O'Garra, Ph.D., FRS, FMedSci# Associate Research Director The Francis Crick Institute Mill Hill Laboratory Wenjun Ouyang, Ph.D. Executive Director Inflammation and Oncology, Research Amgen, Inc. Deborah Palliser, Ph.D. Immunology Strategy Lead Rare Diseases Drug Discovery Unit Takeda Paul W. H. I. Parren, Ph.D. Professor Department of Immunohematology and Blood Transfusion Leiden University Medical Center Mark J. Powers, Ph.D. Senior Director, Research and Development- Cell Biology Thermo Fisher Scientific Bali Pulendran, Ph.D. Professor, Pathology and of Microbiology and Immunology Stanford University School of Medicine Michael H. Rabinowitz, Ph.D. Vice President Research Akebia Therapeutics, Inc Laszlo Radvanyi, Ph.D. President and Scientific Director Ontario Institute for Cancer Research Sridhar Ramaswamy, M.D. Entrepreneur in Residence Google Ventures Richard M. Ransohoff, M.D. Venture Partner Third Rock Ventures Rino Rappuoli, Ph.D. Chief Scientist and Head of External Research and Development GlaxoSmithKline Vaccines Bing Ren, Ph.D. Professor Ludwig Institute for Cancer Research Christopher J. Rhodes, BSc, PhD Chief Scientist, Cardiovascular, Renal & Metabolism, BioPharmaceuticals R&D, AstraZeneca Professor, University of Chicago Mark Rolfe, Ph.D. Corporate Vice President Research & Early Development Celgene Corporation Pamela C. Ronald, Ph.D. Distinguished Professor Plant Pathology and the Genome Center University of California, Davis Cristina M. Rondinone, Ph.D. President Cellarity Inc. Deepak Sampath, Ph.D. Vice President, Head of Research Ultragenyx Thomas J. Schuetz, M.D., Ph.D. Co-Founder, Chief Executive Officer, Director Compass Therapeutics Janine Schuurman, Ph.D. Corporate Vice President Research and Innovation Genmab Ali Shilatifard, Ph.D. Robert Francis Furchgott Professor Chairman, Department of Biochemistry and Molecular Genetics Northwestern University Feinberg School of Medicine Barry P. Sleckman, M.D., Ph.D. Director, O'Neal Comprehensive Cancer Center University of Alabama Birmingham School of Medicine Hans Ulrich Stilz, Ph.D. Vice President R&D Innovation and Outreach Novo Nordisk A/S Boris Striepen, Ph.D. Professor of Microbiology and Immunology Department of Pathobiology School of Veterinary Medicine University of Pennsylvania Lynda M. Stuart, M.D., Ph.D. Deputy Director Global Health, Discovery & Translational Sciences Bill & Melinda Gates Foundation Lori Sussel, Ph.D.# Professor and Director of Research Basic and Translational Research Division, Barbara Davis Center University of Colorado Anschutz Medical Campus Paul K.H. Tam, ChM Li Shu-Pui Professor and Chair of Pediatric Surgery Department of Surgery Director, Dr. Li Dak Sum Research Centre The University of Hong Kong-Karolinska Institutet Collaboration in Regenerative Medicine Cormac Taylor, Ph.D. Professor, Cellular Physiology Medicine University College Dublin Kathrin Tissot, M.D., Ph.D. Business Team Head MorphoSys AG Cornelia Liu Trimble, M.D. Professor Gynecology and Obstetrics, Oncology, and Pathology Johns Hopkins University School of Medicine Fred Van Goor, Ph.D. Principal Research Fellow Research Vertex Pharmaceuticals Incorporated Yibin Wang, Ph.D. Professor Anesthesiology, Physiology and Medicine University of California, Los Angeles David Geffen School of Medicine Andrew B. Ward, Ph.D. Professor Integrative Structural and Computational Biology The Scripps Research Institute Stephanie Wengert Watts, Ph.D. Professor, Assistant Dean Pharmacology & Toxicology Michigan State University Charles E. Whitehurst, Ph.D. Senior Associate Director Immunology and Respiratory Boehringer Ingelheim Pharmaceuticals, Inc. Joseph C. Wu, M.D., Ph.D. Professor and Director of Stanford Cardiovascular Institute Medicine and Radiology Stanford University School of Medicine Xuebiao Yao, Ph.D. Professor and Head Cellular Dynamics University of Science & Technology of China Jonathan Zalevsky, Ph.D. Chief Research & Development Officer Biology Nektar Therapeutics Bei B. Zhang, Ph.D.# Vice President, Metabolic Research Worldwide Research and Development Internal Medicine Pfizer Inc. Juleen R. Zierath, Ph.D.# Professor Department of Molecular Medicine and Surgery Karolinska Institutet Arturo Zychlinsky, Ph.D. Director Cellular Microbiology Max Planck Institute for Infection Biology plus representatives to be announced from: AbbVie Inc. AstraZeneca BlueRock Therapeutics Bristol-Myers Squibb Company Ionis Pharmaceuticals, Inc. Pfizer Inc. Sanofi US |
